NEW YORK (GenomeWeb News) – Sequenom said after the close of the market Monday that it has completed the private placement of $130 million of 5 percent convertible senior notes due 2017.

The San Diego-based molecular diagnostics firm said the placement included $20 million aggregate principal amount of notes from the full exercise of the over-allotment option.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.